1-4 of 4
Authors: Diane Peters
Journal Article
TOWARDS DEVELOPMENT OF TARGETED THERAPEUTICS FOR CHRONIC PAIN IN IBD: ANALGESIC EFFICACY OF AN ORAL GCPII INHIBITOR IN PRECLINICAL VISCERAL PAIN MODELS
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S6, https://doi.org/10.1093/ibd/izae282.016
Published: 28 February 2025
Journal Article
THE ORAL GLUTMATE CARBOXYPEPTIDASE II INHIBITOR (S)-IBD3540 ROBUSTLY ATTENUATES INFLAMMATION IN SPONTANEOUS IL10 COLITIS
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S6, https://doi.org/10.1093/ibd/izac247.014
Published: 26 January 2023
Journal Article
DISCOVERY OF IBD3540: A NOVEL GUT-RESTRICTED GLUTAMATE CARBOXYPEPTIDASE II INHIBITOR WITH ORAL ACTIVITY IN MOUSE COLITIS MODELS
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S4, https://doi.org/10.1093/ibd/izac015.007
Published: 22 January 2022
Journal Article
P152 EVALUATING THE EFFICACY OF GLUTAMATE CARBOXYPEPTIDASE II (GCPII) INHIBITORS IN “WILD-TYPE” MICE: LESSONS LEARNED FROM THE DEDICATOR OF CYTOKINESIS 2 MUTANT MOUSE Get access
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S6, https://doi.org/10.1093/ibd/zaa010.013
Published: 23 January 2020
